Search

everythinglearnresearchcommunity

for

Search:↓

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

A rare case of lupus linked to thymoma shows complex diagnosis and management challenges.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

A vitamin D receptor mutation causes rickets and affects immune responses.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

More research is needed to understand and manage angioedema in pregnant women with lupus.

Erythema multiforme-like lesions can occur in lupus without drug use or herpes infection.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Oral ulcers are common in SLE patients and often link to other symptoms.